Estech (San Ramon, CA) a commercial-stage developer, manufacturer and distributor of temperature controlled RF-based cardiac surgery devices closed a $8.5M Series D financing. Participants include Saints Capital Everest, Telegraph Hill Partners, NBGI Ventures and Tullis Health Investors.

nContact Surgical (Morisville, NC) a clinical-stage medical device company focused on minimally invasive hearth arrhythmias, closed a $16M Series D financing. Participants include Harbert Venture Partners, Intersouth Partners, Massey Burch, Tall Oaks Capital, Village Ventures, Finistere Ventures, Hippo Ventures and ZMV Associates.

SuperDimesnion (Minneapolis, MN) a commercial-stage medical device company focused on minimally invasive distal lung disease treatments, closed a $9.8M Series B financing. Participants include Dan Sullivan Investments, Medica Venture Partners, OrbiMed, Oxford Biosciences Partners and Pitango Venture Capital.

Boston Heart Lab (Framingham, MA) a commercial-stage diagnostics company focused on lipid-based testing for cardiovascular disease management, closed a $10M Series C financing. Participants include Bain Capital Ventures.

Nephera (Israel) a development-stage medical device company focused on kidney function in CHF patients, closed a $2.8M Series B financing. Participants include Aurum Ventures, Evergreen Venture Partners and Trendlines Group.

iRhythm Technologies (San Francisco, CA) a commercial-stage medical device company focused on ambulatory cardiac monitors, closed a $10M Series C financing. Participants include St. Jude Medical, Mohr Davidow Ventures and Synergy Life Science Partners.

CardioDx (Palo Alto, CA) a commercial-stage cardiovascular molecular diagnostics company focused on coronary artery disease, cardiac arrhythmia and heart failure, closed a $5M Series D financing, bring the total round to $34.5M. Participants include GE Healthymagination Fund, Kleiner Perkins Caufield & Byers, TPG Biotech, Intel Capital, Mohr Davidow Ventures, DAG Ventures, Pappas Ventures and Asset [...]

Reverse Medical (Irvine, CA) a commercial-stage medical device company focused on revascularizing patients experiencing Acute Ischemic Stroke, closed a $14M Series B financing. Participants include Wexford Capital, BioStar Ventures, Early Stage Partners, Emergent Medical Partners, NBGI Ventures and MedFocus Funds.

Cheetah Medical (Israel) a commercial-stage device company focused on non-invasive cardiac output and hemodynamic monitoring, closed a $20M Series B financing. Participants include Ascension Health Ventures, Robert Bosch Venture Capital and MVM Life Science Partners.

Valtech Cardio (Israel) a development-stage medical device company focused on minimally invasive percutaneous annuloplasty ring valve repair for the treatment of mitral valve regurgitation, closed a $17.8M Series B financing. Participants include OXO Capital, NGN Capital and Peregrine Ventures.

CicuLite (Saddle Brook, NJ) a clinical-stage medical device company focused on minimally invasive implantable devices for chronic heart failure, closed a $32.5M Series C financing. Participants include Forbion Capital Partners, Crédit Agricole Private Equity, Foundation Medical Partners and Oxford Bioscience Partners.

Direct Flow Medical (Santa Rosa, CA) a development-stage medical device company focused on a percutaneous aortic tissue valve prosthesis, closed a $40M Series C financing. Participants include Johnson & Johnson Development Corp., Foundation Medical Partners, VantagePoint Venture Partners, ePlanet Ventures, EDF Ventures, New Leaf Venture Partners and Spray Venture Partners.

Endosense (Switzerland) a commercial-stage medical device company focused on catheter ablation for the treatment of cardiac arrhythmias, closed a $36M Series B financing. Participants include Edmond de Rothschild Investment Partners, Neomed, Gimv, VI Partners, Sectoral Asset Management, Ysios Capital and Initiative Capital Romandie.